object
character
two
achromobact
xylosoxidan
recov
patient
diagnos
pertussi
bordetella
pertussi
surveil
program
method
nasopharyng
swab
children
year
age
clinic
suspicion
pertussi
analyz
cultur
pcr
result
two
achromobact
xylosoxidan
close
relat
bordetella
spp
recov
patient
diagnos
pertussi
carri
ptxa
gene
pertussi
toxin
encod
gene
subsequ
antibiot
suscept
evalu
diskdiffus
method
pcr
conclus
although
detail
studi
need
present
data
highlight
possibl
achromobact
xylosoxidan
close
relat
bordetella
pertusssi
microorgan
cover
vaccin
umbrella
might
also
result
case
whoop
cough
therebi
surveil
necessari
determin
extens
relev
pathogen
role
order
discrimin
real
public
health
implic
respiratori
tract
infect
lead
caus
mortal
among
children
five
year
age
worldwid
caus
around
million
death
yearli
especi
low
middl
incom
countri
lmc
among
infect
whoop
cough
pertussi
particularli
sever
report
million
case
pertussi
around
death
worldwid
lmc
pertussi
caus
bordetella
pertussi
b
pertussi
potenti
prevent
vaccin
character
seri
earli
symptom
may
easili
misdiagnos
common
cold
follow
seri
paroxysm
symptom
week
evolut
may
includ
cough
whoop
sound
vomit
among
other
might
result
death
introduct
pertussi
vaccin
result
decreas
diseas
burden
sinc
last
centuri
number
case
risen
reemerg
pertussi
may
relat
differ
caus
includ
less
effect
current
acellular
pertussi
vaccin
respect
whole
cell
vaccin
select
variant
b
pertussi
cover
vaccin
well
underestim
role
bordetella
speci
bordetella
holmesii
follow
trend
last
year
increas
number
case
mainli
rural
area
describ
peru
member
achromobact
genu
ubiquit
detect
differ
sourc
includ
water
environ
differ
human
microbiota
achromobact
genu
close
relat
bordetella
propos
potenti
virul
evolutionari
point
view
line
achromobact
xylosoxidan
xylosoxidan
describ
caus
differ
infect
mainli
bacteremia
immunosuppress
patient
also
relat
respiratori
diseas
includ
infect
patient
cystic
fibrosi
bronchiectasi
pleural
emphysema
among
other
howev
knowledg
never
report
causal
agent
pertussislik
ill
aim
studi
character
xylosoxidan
isol
pediatr
patient
diagnos
whoop
cough
nasopharyng
swab
children
year
age
clinic
suspicion
pertussi
collect
surveil
pertussi
sent
instituto
de
nutricionaluniversidad
peruana
de
ciencia
aplicada
relev
clinic
data
record
questionnair
studi
approv
ethic
committe
hospit
nacion
de
salud
del
lima
peru
sampl
collect
parent
provid
sign
inform
consent
clinic
epidemiolog
featur
regist
patient
includ
age
clinic
symptom
paroxysm
cough
cyanosi
respiratori
distress
difficulti
feed
fever
flush
diarrhea
vomit
wheez
runni
nose
expector
day
onset
symptom
time
elaps
sampl
collect
sent
laboratori
direct
nucleic
acid
extract
perform
nasopharyng
sampl
use
high
pure
templat
prepar
kit
roch
appli
scienc
mannheim
germani
follow
manufactur
instruct
pertussi
statu
confirm
pcr
thu
bp
ptxa
gene
bp
amplifi
use
primer
describ
elsewher
confirm
correct
amplif
pcr
product
recov
purifi
spinpreptm
gel
dna
kit
san
diego
usa
sequenc
macrogen
seoul
korea
addit
presenc
adenoviru
influenza
b
c
syncyti
respiratori
viru
b
parainfluenza
enteroviru
rhinoviru
coronaviru
verifi
describ
elsewher
nasopharyng
sampl
cultur
bordetgeng
agar
incub
c
moist
atmospher
maintain
day
aerob
condit
coloni
identifi
base
characterist
morpholog
gram
stain
appear
catalas
oxidas
test
posit
cultur
confirm
pcr
ptxa
gene
mention
previous
addit
dna
fragment
bp
includ
first
bp
parc
gene
also
amplifi
use
primer
condit
previous
describ
ohtsuka
et
al
primer
abl
amplifi
parc
gene
bordetella
spp
xylosoxidan
may
easili
differenti
presenc
sever
addit
nucleotid
ntermin
region
parc
gene
xylosoxidan
sequenc
suscept
level
amoxicillin
azithromycin
chloramphenicol
cotrimoxazol
erythromycin
clarithromycin
cefotaxim
ampicillin
moxifloxacin
tetracyclin
perform
disk
diffus
rrna
gene
amplifi
bacteri
dna
extract
use
primer
condit
describ
previous
addit
rplv
rpld
gene
nasopharyng
swab
bacteri
origin
amplifi
use
bordetellaspecif
primer
rplvf
children
present
fever
respiratori
distress
flush
one
present
cough
paroxysm
tabl
one
children
treat
amoxicillin
plu
cephalexin
mg
receiv
ceftriaxon
mg
case
treatment
success
children
discharg
hospit
case
pcr
direct
dna
extract
nasopharyng
swab
posit
presenc
ptxa
gene
show
ident
b
pertussi
genbank
access
number
addit
none
pathogen
sought
detect
thu
patient
diagnos
pertussi
antibiot
suscept
analysi
show
isol
present
high
level
resist
test
antibacteri
agent
includ
analyz
macrolid
tabl
surprisingli
macrolid
target
encod
gene
amplifi
sequenc
result
show
presenc
xylosoxidan
rrna
gene
rpld
gene
rplv
gene
ident
respect
dna
sequenc
xylosoxidan
genbank
access
even
higher
ident
level
dna
sequenc
b
pertussi
genbank
access
bordetella
spp
result
also
confirm
pcr
analysi
grown
microorgan
identif
tool
includ
analysi
parc
gene
sequenc
also
show
closest
relat
sequenc
xylosoxidan
amino
acid
codon
longer
achromobact
spp
bordetella
spp
parc
sequenc
present
genbank
thu
despit
presenc
differ
ident
encod
parc
dna
sequenc
sampl
show
differ
amino
acid
chang
regard
aforement
macrolid
target
mutat
found
rrna
gene
silent
mutat
found
rpld
gene
comparison
xylosoxidan
wildtyp
sequenc
silent
mutat
plu
transvers
result
amino
acid
chang
observ
rplv
gene
achromobact
spp
frequent
environment
microorgan
caus
seri
opportunist
ill
includ
respiratori
diseas
possess
high
evolutionari
virul
potenti
phylogenet
proxim
bordetella
line
descript
xylosoxidan
pediatr
whoop
cough
patient
strongli
suggest
implic
etiolog
agent
especi
isol
analysi
show
presenc
ptxa
gene
well
dna
fragment
includ
ntermin
parc
gene
also
amplifi
confirm
data
gene
select
ntermin
section
xylosoxidan
amino
acid
describ
parc
bordetella
spp
moreov
sequenc
also
amino
acid
longer
parc
achromobact
presenc
nonb
pertussi
microorgan
caus
whoop
cough
direct
implic
lack
diminish
protect
vaccin
direct
public
health
impact
nonetheless
case
one
child
partial
vaccin
sinc
first
vaccin
dosag
provid
month
life
present
variabl
copi
number
differ
bordetella
genu
member
socal
pertussi
toxin
exclus
produc
b
pertussi
howev
differ
member
genu
bordetella
bordetella
bronchiseptica
bordetella
parapertussi
involv
etiolog
caus
ill
possess
close
relat
nonfunct
gene
bordetella
genu
member
b
holmesii
account
diagnos
pertussi
case
present
either
pertussi
toxin
gene
closerel
gene
characterist
use
differ
studi
facilit
differenti
b
pertussi
b
holmesii
thu
pertussi
toxin
function
although
relev
essenti
presenc
pertussislik
symptom
case
data
gene
function
obtain
remain
establish
studi
ongo
antimicrobi
suscept
analysi
show
high
level
resist
macrolid
matter
concern
sinc
macrolid
consid
treatment
choic
pertussi
highlight
need
correctli
determin
etiolog
agent
caus
ill
along
line
report
differ
bordetella
speci
present
differ
level
macrolid
resist
especi
high
b
holmesii
regard
macrolid
target
amino
acid
codon
alter
respect
xylosoxidan
wildtyp
sequenc
observ
rplv
gene
thu
amino
acid
codon
substitut
observ
protein
isol
howev
best
knowledg
substitut
amino
acid
codon
equival
posit
microorgan
relat
macrolid
resist
nonetheless
presenc
specif
amino
acid
chang
may
polymorph
without
involv
develop
macrolid
resist
obvious
presenc
transfer
mechan
macrolid
resist
rule
thu
genbank
search
show
presenc
ere
gene
member
achromobact
genu
genbank
access
interestingli
silent
dna
mutat
found
strain
rplv
rpld
parc
gene
close
similar
two
isol
togeth
short
isol
frame
time
two
isol
suggest
presenc
specif
xylosoxidan
clone
close
relat
microorgan
abil
caus
pertussislik
ill
area
take
account
recent
report
spilker
et
al
special
interest
author
report
presenc
sever
new
put
bordetellalik
speci
suggest
presenc
undescrib
genu
close
relat
xylosoxidan
bordetella
spp
summari
present
result
show
presenc
xylosoxidan
microorgan
possess
ptxa
gene
due
proxim
achromobact
genom
bordetella
spp
caus
whoop
cough
depth
character
isol
recov
need
present
data
highlight
possibl
close
relat
b
pertusssi
microorgan
cover
vaccin
umbrella
might
also
result
case
whoop
cough
therebi
requir
surveil
determin
extens
relev
pathogen
role
order
discrimin
real
public
health
implic
